Clinigen Group PLC (CLINC.L)

CLINC.L on London Stock Exchange

549.00GBp
21 Nov 2014
Price Change (% chg)

10.00p (+1.86%)
Prev Close
539.00p
Open
535.00p
Day's High
550.00p
Day's Low
535.00p
Volume
276,042
Avg. Vol
153,501
52-wk High
690.00p
52-wk Low
354.92p

CLINC.L

Chart for CLINC.L

About

Clinigen Group plc (Clinigen) is a specialty pharmaceuticals and services business company. The Company operates in three segments: Clinical Trial Supply, Specialty Pharmaceuticals and Global Access Programs. Clinical Trial Supply division is involved in the sourcing and supply of comparator products for Clinical Trials.... (more)

Overall

Beta: --
Market Cap (Mil.): £444.97
Shares Outstanding (Mil.): 82.56
Dividend: 2.10
Yield (%): 0.58

Financials

  CLINC.L Industry Sector
P/E (TTM): 28.34 269.72 39.20
EPS (TTM): 0.19 -- --
ROI: 27.65 -1.77 17.16
ROE: 27.65 -3.18 18.09
Search Stocks

BRIEF-Clinigen buys AstraZeneca's oncology support drug Ethyol

* Further strengthens oncology support portfolio with acquisition of ethyol (amifostine), from astrazeneca

20 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Peel Hunt
$69.00
Provider: Peel Hunt
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks